Orleans Capital Management Corp LA Trims Position in Procter & Gamble Company (The) $PG

Orleans Capital Management Corp LA decreased its position in Procter & Gamble Company (The) (NYSE:PG) by 27.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 14,153 shares of the company’s stock after selling 5,340 shares during the quarter. Procter & Gamble makes up 1.4% of Orleans Capital Management Corp LA’s portfolio, making the stock its 22nd biggest holding. Orleans Capital Management Corp LA’s holdings in Procter & Gamble were worth $2,175,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC boosted its holdings in shares of Procter & Gamble by 51.5% in the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after buying an additional 13,617 shares during the last quarter. Taylor Financial Group Inc. increased its holdings in Procter & Gamble by 10.6% during the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after buying an additional 277 shares during the last quarter. Sivia Capital Partners LLC raised its position in Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after acquiring an additional 1,016 shares during the period. Auxano Advisors LLC raised its position in Procter & Gamble by 10.8% in the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock worth $1,165,000 after acquiring an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. boosted its stake in shares of Procter & Gamble by 2.8% during the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock worth $4,809,000 after acquiring an additional 809 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple dividend-themed pieces reaffirm PG’s status as a Dividend King/Aristocrat, underscoring steady dividend growth and defensive appeal for income-focused investors; that support can reduce downside for long-term holders. Dividend Aristocrats in a Shaky Market
• Neutral Sentiment: Market context is jittery (rising VIX, weak consumer sentiment and still-elevated Treasury yields); that macro uncertainty is affecting broad equity flows and may amplify short-term moves in consumer staples despite PG’s defensive profile. Dividend Aristocrats in a Shaky Market
• Negative Sentiment: A recent compendium of analyst notes flags margin pressure for Procter & Gamble, creating concern about near-term profitability and earnings leverage. That negative analyst tone can weigh on the stock. Top Research Reports for Procter & Gamble, American Express & TJX
• Negative Sentiment: Reports show PG shares have recently fallen more steeply than the broader market, indicating stronger selling pressure in short-term trading sessions. That price action can feed momentum-driven outflows. Procter & Gamble (PG) Falls More Steeply Than Broader Market
• Negative Sentiment: Insider selling was reported recently, which investors often view as a near-term negative signal and can amplify caution among holders and prospective buyers. Procter & Gamble (NYSE:PG) Shares Down 2.3% Following Insider Selling

Procter & Gamble Stock Down 0.1%

PG opened at $153.80 on Friday. The company has a market capitalization of $357.43 billion, a PE ratio of 22.79, a price-to-earnings-growth ratio of 5.15 and a beta of 0.37. The firm has a 50-day simple moving average of $152.35 and a two-hundred day simple moving average of $151.21. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $179.99.

Procter & Gamble (NYSE:PG) last issued its earnings results on Thursday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. The firm had revenue of $22.21 billion for the quarter, compared to analysts’ expectations of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The business’s revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.67%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on PG. UBS Group boosted their price objective on shares of Procter & Gamble from $161.00 to $170.00 and gave the company a “buy” rating in a research report on Friday, January 23rd. TD Cowen cut Procter & Gamble from a “buy” rating to a “hold” rating and raised their target price for the stock from $150.00 to $156.00 in a report on Tuesday, January 27th. Dbs Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. JPMorgan Chase & Co. upgraded Procter & Gamble from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $157.00 to $165.00 in a research report on Friday, January 23rd. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Tuesday, February 17th. Fourteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $168.33.

Insiders Place Their Bets

In related news, CEO Ma. Fatima Francisco sold 5,549 shares of the firm’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the completion of the transaction, the chief executive officer directly owned 1,029 shares of the company’s stock, valued at approximately $170,083.41. This trade represents a 84.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Susan Street Whaley sold 1,809 shares of the business’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $159.46, for a total transaction of $288,463.14. Following the completion of the sale, the insider owned 30,215 shares in the company, valued at $4,818,083.90. This represents a 5.65% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 348,618 shares of company stock worth $55,462,643. Insiders own 0.20% of the company’s stock.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.